claim
There is a robust literature of studies establishing the safety and efficacy of ketamine-assisted treatment for depression (Salahudeen et al. 2020) and increasingly high-quality studies on psilocybin-based therapies for depression (Carhart-Harris et al. 2021; Davis et al. 2020), though larger and more robust clinical trials are still needed.
Authors
Sources
- Ancient Roots of Today's Emerging Renaissance in ... link.springer.com via serper
Referenced by nodes (3)
- ketamine concept
- psilocybin concept
- depression concept